In Brief Srivastava et al. report that M. tuberculosis uses a vesicular transport pathway to divert bacterial antigens from the MHC class II pathway and out of infected cells, minimizing CD4 T cell activation and promoting bacterial persistence. Drugs that block antigen export may enhance the efficacy of T cells in TB.
INTRODUCTION
Infection with Mycobacterium tuberculosis is a major global health problem, due to its ease of transmission by the aerosol route, the lack of an efficacious vaccine, and increasing emergence of bacterial drug resistance (Philips and Ernst, 2012) . Even though the HIV pandemic has amplified the global problem of tuberculosis (TB), most people with TB are immunocompetent, indicating that M. tuberculosis possesses effective mechanisms for evasion of innate and adaptive immunity. Although the onset of adaptive immune responses is delayed after M. tuberculosis infection of humans (Poulsen, 1950) or mice (Chackerian et al., 2002; Gallegos et al., 2008; Reiley et al., 2008; Wolf et al., 2008) , most infected individuals and experimental animals develop antigen-specific CD4 and CD8 T cell responses, and the resulting T cells have appropriate effector functions as assessed by ex vivo restimulation (Ernst, 2012) .
However, M. tuberculosis persists despite measurable T cell responses, suggesting that the bacteria manipulate the host to prevent effector T cells from exerting their functions at the site of infection (Urdahl et al., 2011) .
Since M. tuberculosis resides in macrophages and DCs in vivo (Tailleux et al., 2003; Wolf et al., 2007) , the suboptimal efficacy of effector T cells may not be due to an intrinsic property of the antigen-specific effector T cells themselves, but instead may be secondary to bacterial manipulation of the infected antigen-presenting cells. Indeed, multiple studies have reported that mycobacterial infection of antigen-presenting cells interferes with MHC class II antigen presentation in vitro, although the mechanisms that interfere with antigen presentation are poorly understood (reviewed in Baena and Porcelli, 2009) . Likewise, it is unclear whether the phenomenon observed in vitro contributes to suboptimal CD4 T cell efficacy in vivo (Ernst, 2012) .
We recently reported that M. tuberculosis-infected host cells export bacterial antigens for uptake and presentation by uninfected cells, and we and Pamer and colleagues found that antigen transfer to uninfected DCs in the lymph node allows priming of CD4 T cells in vivo (Samstein et al., 2013; Srivastava and Ernst, 2014) , implying that this phenomenon helps to compensate for impaired antigen presentation by M. tuberculosis-infected cells (Hudrisier and Neyrolles, 2014) . Because of the potential importance of antigen transfer for immunity to TB, we sought to further understand its underlying mechanisms and significance. Here we report the unexpected finding that the first stage of antigen transfer, antigen export, benefits the pathogen by shunting bacterial antigens away from the MHC class II antigen presentation pathway, thereby minimizing recognition of infected cells by antigen-specific CD4 T cells. We also discovered that the second stage of antigen transfer, antigen uptake and presentation by uninfected cells, only partially compensates for the impaired antigen presentation capacity of infected cells. Our results indicate that antigen export is a potent and effective mechanism of immune evasion that promotes persistence M. tuberculosis despite development of antigen-specific T cell responses.
RESULTS

Evidence for Antigen Export and Transfer to Uninfected Lung Cells In Vivo
We first confirmed and extended our finding that M. tuberculosis antigens can be acquired by uninfected cells in vivo in a process of antigen export from infected cells followed by uptake and processing by uninfected bystander cells. In addition to the earlier finding of antigen transfer in lymph nodes after aerosol infection (Samstein et al., 2013; Srivastava and Ernst, 2014) , we found that antigen transfer occurs in the lungs. After infecting mice with GFP-expressing M. tuberculosis, we isolated and sorted live lung leukocytes on the basis of their phenotype and presence (GFP+) or absence (GFPÀ) of intracellular bacteria and used the sorted cells to stimulate M. tuberculosis Ag85B-specific TCR transgenic (P25TCR-Tg) CD4 T cells. We found that the distinct subsets of infected cells (lung DC, recruited interstitial macrophages, and monocytes) differed in their capacity to activate CD4 T cells in vitro ( Figure S1A ). Notably, uninfected cells in each of the three subsets also activated CD4 T cells in this assay. Indeed, in all three subsets, the uninfected cells were superior to the infected cells, indicating that they had acquired bacterial antigen for processing and presentation to CD4 T cells.
To assure that antigen acquisition by uninfected myeloid cells in the lungs was not an artifact of cell isolation and sorting, we stained frozen lung sections from mice that had been infected with GFP-expressing M. tuberculosis. This demonstrated that both infected (GFP + ) and uninfected (GFP À ) CD11c+ cells contain Ag85 and that the uninfected cells that had acquired Ag85 were in proximity to infected cells, implying that they had acquired antigen released from infected cells ( Figure S1B ).
M. tuberculosis Ag85 Is Present in Extraphagosomal Vesicles in Infected Cells
To further understand the significance of antigen export, we first sought to identify cellular mechanistic steps required for antigen export from infected cells. Since our earlier studies indicated that M. tuberculosis antigen export from infected cells did not involve apoptosis or exosome shedding, and released undegraded bacterial proteins, we used immunofluorescence staining and confocal microscopy to localize M. tuberculosis antigen 85 (Ag85) in infected cells. Ag85, which consists of the closely related proteins Ag85A, Ag85B, and Ag85C, is secreted by M. tuberculosis and is a component of multiple TB vaccine candidates currently in development (Kaufmann et al., 2014) . We found Ag85 (principally Ag85B) staining in a punctate pattern in DCs infected with wild-type, but not with Ag85B-null M. tuberculosis ( Figure 1A ). Punctate staining of Ag85 was not concentrated in the perinuclear region, and Ag85+ puncta were present in the periphery of the infected cells. Since the punctate pattern suggested that Ag85 is contained in vesicles, we used immunogold staining and electron microscopy of cryosectioned M. tuberculosis-infected bone-marrow-derived DCs to further characterize the location of extraphagosomal intracellular Ag85. This revealed Ag85 in bacteria-containing phagosomes and in small membrane-bound vesicles devoid of bacteria or electron-dense bacterial fragments ( Figure 1B ). This finding resembles the reported location of Ag85 in M. tuberculosis-infected human monocytes (Harth et al., 1996) and murine macrophages (Beatty and Russell, 2000) , determined using a different antibody to Ag85. While the fixation conditions compatible with immunogold staining are not optimal for preservation of membrane ultrastructure, the Ag85-containing vesicles detected were bounded by a single bilayer ( Figure 1B , inset). We refer to these vesicles as antigen export vesicles (AEVs).
Phagosomes containing live mycobacteria, including M. tuberculosis, have been reported to interact with recycling endosomes containing transferrin and transferrin receptors Sturgill-Koszycki et al., 1996) . We therefore hypothesized that AEVs might be equivalent to recycling endosomes that acquired bacterial proteins present from the lumenal space of phagosomes, trafficked to the cell surface, and released their cargo to the extracellular space. However, immunofluorescence microscopy revealed lack of colocalization of extraphagosomal Ag85 and transferrin receptor-bearing endosomes ( Figures 1C and 2D ). Similar findings were obtained when recycling endosomes were labeled using fluorescently labeled transferrin (not shown). These findings indicate that AEVs are not classical recycling endosomes that have intersected with M. tuberculosis-containing phagosomes. They also imply that an additional population of intracellular vesicles interacts with mycobacterial phagosomes and is involved in transport of bacterial products from phagosomes to the extracellular space. We also found that most, but not all of the AEVs are segregated from MHC class II-containing vesicles in infected cells ( Figure 1D ), suggesting that a limited fraction of Ag85 is present in the MHC-II pathway; AEVs also did not resemble early endosomes, as they did not colocalize with EEA1 (not shown).
Export of M. tuberculosis Ag85B from Infected Cells
Involves the Motor Protein Kinesin-2 Although the mechanisms of exocytosis and protein secretion from macrophages and DCs are incompletely characterized, microtubule-dependent vesicle transport promotes secretory vesicle transport and exocytosis in diverse cell types, from neurons to cytotoxic T lymphocytes (Kuhn and Poenie, 2002; Stinchcombe et al., 2006; Vale et al., 1985) . Immunofluorescence confocal microscopy revealed a high frequency of localization of AEVs with microtubules in M. tuberculosis-infected cells (Figures 2A and 2D) . AEVs were closely aligned with microtubules, including at the periphery of infected cells (Figure 2A ). AEVs (red) frequently colocalized with tubulin (green), as indicated by yellow fluorescence; in addition, AEVs were frequently in close proximity to microtubules. To determine the functional significance of colocalization of AEVs and microtubules, we inhibited tubulin polymerization using nocodazole and observed a dosedependent decrease in the extracellular release of Ag85 (Figure 2B) . The maximum tolerated concentration of nocodazole decreased Ag85B export by approximately 50%. These results are consistent with microtubule-dependent vesicular transport as an essential step in export of an M. tuberculosis antigen from infected cells.
Microtubule-dependent organelle transport toward the cell periphery depends on one or more members of the kinesin family of motor proteins (reviewed in Hirokawa et al., 2009 ). We examined kinesin-2, since it is implicated in transport of vesicular organelles; its subunits, KIF3A, KIF3B, and KIF-associated protein 3 (KAP3 or KIFAP3) are expressed in macrophages and myeloid DCs Miller et al., 2012) (Gaudin et al., 2012) . Immunofluorescence confocal microscopy revealed that AEVs colocalized with the kinesin-2 component KIF3A in infected cells ( Figure 2C ). We used automated image analysis to quantitate the fraction of AEVs that colocalized with microtubules and/or with KIF3A in 100-300 infected cells and found that in the majority of infected cells, >60% of AEVs colocalized with tubulin or KIF3A (Figure 2D ), suggesting that microtubule associated kinesin-2 contributes to trafficking of AEV. In contrast, less than 20% of Ag85+ AEVs colocalized with transferrin receptor-containing vesicles in any infected cell ( Figure 2D ). Since members of the dynamin protein family mediate vesicle budding and membrane scission in diverse intracellular processes (Ferguson and De Camilli, 2012; Praefcke and McMahon, 2004) , we hypothesized that dynamin-2 (the form expressed in myeloid cells) might contribute to generation and/or maturation of AEV and found that in the majority of cells 40%-60% of Kinesin-2 Depletion Blocks Antigen Export from Infected Cells Since disruption of microtubule polymerization decreased export of Ag85 from infected cells, and AEVs colocalized with microtubules and with KIF3A, we examined the functional importance of kinesin-2 in antigen export. Kinesin-2 typically functions as a heterotrimer of KIF3A, KIF3B, and KIF3 adaptor protein (KAP3 or KIFAP3) (Cole et al., 1993; Hirokawa et al., 2009 ), so we used siRNAs targeting KIF3A and KAP3 to deplete kinesin-2. siRNA treatment of infected cells resulted in marked depletion of both KIF3A and KAP3 as indicated by immunoblots of cell lysates ( Figures 3A and S2A) . Depletion of these components of kinesin-2 decreased export of Ag85B from infected cells by approximately 70%, as assayed by transferring conditioned medium to naive uninfected DC, which were then used to activate Th1-polarized Ag85B-specific TCR transgenic (P25TCR-Tg) CD4 T cells ( Figures 3B and S2B ). Kinesin-2 depletion decreased the concentration of Ag85B protein in conditioned medium by a similar amount as detected by immunoblotting, without a difference in the number of bacteria in kinesin-2-depleted and control cells ( Figures 3C, S2C , and S2D). Kinesin-2 depletion also decreased export of at least three other M. tuberculosis antigenic proteins, ESAT-6, CFP-10, and EsxH ( Figures 3C, S2C , and S2D), indicating that the export pathway of these proteins from M. tuberculosis-infected cells resembles that of Ag85B. A similar decrease of exported bacterial antigens was observed when infected macrophages were used instead of DC ( Figures 3D and 3E ). The finding that export of M. tuberculosis antigens from infected cells depends on kinesin-2 is consistent with the results that implicated an intact microtubule cytoskeleton in antigen export. Moreover, the finding that kinesin-2 is required for export of at least four M. tuberculosis proteins, which are secreted by the bacteria using three distinct secretion systems (Ag85: SecA1; ESAT-6 and CFP-10: the type VII secretion system, Esx-1; and EsxH: Esx-3) indicates that AEVs export multiple bacterial proteins that are targets of T cell recognition.
To further characterize AEVs and the process of antigen export, we examined the functional role of dynamin 2, which mediates budding and scission of diverse populations of intra- (D) Quantitative analysis of the fraction of AEVs that colocalize with tubulin, KIF3A, dynamin 2, or transferrin receptor (TfR) in a given cell. Confocal z stack images were acquired and analyzed using the Manders' overlap coefficient (Dunn et al., 2011) analysis module of the Volocity image analysis software. Data in (A)-(D) represent two to four independent experiments where 100-300 cells were analyzed to obtain the Manders' colocalization coefficient. Data shown are mean ± SD. A similar trend with respect to colocalization was confirmed by analysis with the JACoP (Just another colocalization plugin) of the ImageJ software (Costes et al., 2004) . cellular vesicles (Ferguson and De Camilli, 2012) , and since immunofluorescence microscopy revealed evidence for association of AEVs and dynamin 2. We first depleted dynamin 2 from DCs using siRNA prior to infection, but this reduced uptake of the bacteria, consistent with the previously reported role of dynamin 2 in phagocytosis (Gold et al., 1999) . As an alternative, we took advantage of the rapid kinetics of dynasore, a cell-permeable chemical inhibitor of dynamin GTPase activity (Macia et al., 2006) , and added it to DCs after infection with M. tuberculosis. Dynamin inhibition reduced export of Ag85B by $60%, as reflected by immunoblotting of CM and by activation of P25TCR-Tg Th1 cells after transfer of CM to fresh DCs ( Figure 3F , left panel). The decreased responses of P25TCR-Tg cells to CM from dynasore-treated infected DCs were due to decreased availability of antigen in CM and not due to dynasore carried over into the T cell response assay, since P25TCR-Tg cells were able to respond when recombinant Ag85B was added to CM from dynasore-treated DCs ( Figure 3F ; right panel). Together, the findings that dynamin 2 associates with AEVs and that dynamin inhibition blocks antigen export imply a role for dynamin 2 in one or more vesicle membrane budding/scission events in the antigen export pathway.
Blocking Antigen Export Decreases CD4 T Cell Priming by Bystander Cells and Increases T Cell Priming by Infected Cells In Vivo
To determine whether kinesin-2-dependent antigen export impacts activation of Ag85B-specific CD4 T cells in vivo, we used intratracheal transfer of M. tuberculosis-infected bone-marrowderived DC, followed by assay of P25TCR-Tg CD4 T cell proliferation in the mediastinal lymph node of recipient mice (Srivastava and Ernst, 2014) . Transfer of M. tuberculosis-infected kinesin-2-depleted MHC II À/À DCs (that are impaired in antigen export and also cannot directly activate CD4 T cells) to naive MHC II +/+ recipients resulted in less proliferation of antigen-specific CD4 T cells than observed when infected kinesin-2 replete MHC II À/À DCs were transferred ( Figures 4A-4D ). These results support our in vitro observations that kinesin-2 depletion in infected DCs decreases export of bacterial antigens and decreases availability of antigen that can be acquired and presented by bystander cells.
To determine the impact of blocking antigen export on the ability of infected cells to directly present antigen and activate antigen-specific CD4 T cells, we transferred M. tuberculosis-infected kinesin-2-depleted or kinesin-2-replete MHC class II +/+ DCs into MHC class II À/À recipients and assayed proliferation of adoptively transferred naive P25TCR-Tg CD4 T cells. This yielded the unexpected result that kinesin-2-depleted DCs (which are impaired in antigen export) stimulated more T cell proliferation than did DCs that were treated with a control siRNA ( Figures 4E-4H) ; this was not due to differences in the number of bacteria in the transferred DCs nor to enhanced migration of kinesin-2-depleted DCs to the local lymph node ( Figures S3A-S3C ). Since the only cells that can activate CD4 T cells under these conditions are the infected, transferred DCs, this result indicates that disrupting antigen export increases the antigen presenting efficacy of M. tuberculosis-infected cells. These results indicate that antigen export is a mechanism that decreases MHC class II antigen presentation by M. tuberculosis-infected cells.
Antigen Export Limits Overall CD4 T Cell Activation In Vivo Our previously published finding that M. tuberculosis-infected cells export antigen for uptake and presentation by uninfected bystander cells implied that antigen transfer compensates for impaired antigen presentation by infected cells (Srivastava and Ernst, 2014) . In the context of those results, our finding that blocking antigen export could increase antigen presentation by infected cells raised the question whether antigen transfer to bystander cells fully compensates for impaired antigen presentation by infected cells. To address this question, we transferred wild-type M. tuberculosis-infected kinesin-2-depleted (impaired for antigen transfer) or control (competent for antigen transfer) DCs into wild-type mice and quantitated proliferation of adoptively transferred naive P25TCR-Tg CD4 T cells. This revealed quantitatively greater proliferation of antigen-specific CD4 T cells in recipients of kinesin-2-depleted DCs compared with that in recipients of control DCs ( Figures  5A-5D) ; this was not due to a difference in the number of antigen-producing bacteria in the two groups of cells or a difference in their ability to migrate to the local lymph node (Figures S4A-S4D ). These results indicate that blocking antigen export enhances CD4 T cell activation to a greater extent than can be accomplished by antigen export followed by antigen uptake and presentation by bystander cells. These results also indicate that antigen export is a quantitatively significant mechanism that reduces MHC class II antigen presentation by M. tuberculosis-infected cells.
Blocking Antigen Export Enhances Activation of Antigen-Specific Th1 Effector T Cells and T CellDependent Antimycobacterial Activity
The unexpected finding that blocking antigen transfer in vivo enhances priming and proliferation of naive CD4 T cells suggested that blocking antigen transfer might also enhance activation of CD4 effector T cells. When varying numbers of kinesin-2-depleted or control DCs infected with M. tuberculosis were cultured with a constant number of Ag85B-specific Th1-polarized P25TCR-Tg CD4 T cells, kinesin-2-depleted DCs were superior to kinesin-2-replete DCs at all DC:T cell ratios examined, with 3-fold greater T cell activation by kinesin-2-depleted cells at the lowest DC:T cell ratio examined (Figure 6A ). Enhanced activation of antigen-specific CD4 effector cells was due to enhanced presentation of antigen produced by intracellular bacteria and not due to increased surface expression of MHC II or costimulatory molecules, differential apoptosis, or cytokine secretion; depletion of kinesin-2 in DCs did not affect activation of Ag85B-specific CD4 T cells (H) Quantitation of P25TCR-Tg cells that underwent R 1 cycle of proliferation (CFSE dim ) in lymph nodes of groups of mice in (G). Data are mean± SEM of three pools of mice (n = 6) per experimental group and represent two independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001 (Student's t test).
when antigen was provided as recombinant Ag85B or as peptide 25 ( Figures S5A-S5E) . At a constant ratio of DC:effector T cells, enhanced activation of CD4 effector cells by kinesin-2-depleted DCs depended on the dose of siRNA used; as little as 25 nM siRNA caused a significant increase in T cell secretion of IFNg ( Figure 6B ). Kinesin-2 depletion did not affect uptake of M. tuberculosis, as reflected by the number of viable bacteria present immediately following infection, prior to addition of P25TCR-Tg Th1 cells ( Figure S5F ). The evidence that blocking antigen export from M. tuberculosis-infected cells caused increased CD4 effector T cell activation suggested that blocking antigen export might also enhance T-cell-dependent control of intracellular M. tuberculosis infection. When Ag85B-specific P25TCR-Tg Th1 cells were cocultured with M. tuberculosis-infected bone marrow DCs that were depleted of kinesin-2 by treatment with KIF3A and KAP3 siRNAs, there was an siRNA dose-dependent decrease in the number of viable bacteria recovered after 20 hr, compared with that in export-competent control cells (Figure 6C) . The decreased recovery of viable bacteria was not a consequence of decreased DCs viability or bacterial uptake (Figure S5F) , indicating that inhibition of antigen export not only increased activation of antigen-specific CD4 T cells but also improved T-cell-dependent control of intracellular infection. The apparent threshold for improved bacterial control was higher than that required for increased CD4 T cell activation: treatment of DCs with 25 nM siRNA was sufficient to increase activation of antigen-specific CD4 T cells, while 50 nM was required to enhance control of intracellular M. tuberculosis. In these experiments, CD4 T cell activation and bacterial control required both MHC class II and specific antigen, as MHC-II À/À DCs infected 
DISCUSSION
The studies reported here reveal that DCs and macrophages infected with Mycobacterium tuberculosis divert mycobacterial antigens away from the MHC class II antigen presentation pathway and to the extracellular space, and by doing so reduce their activation of CD4 T cells, leading to improved survival of the intracellular bacteria. Although we and others have previously reported that antigen transfer from infected to uninfected DCs after aerosol infection provides a mechanism to compensate for impaired antigen presentation by infected cells (Samstein et al., 2013; Srivastava and Ernst, 2014) , our present results provide two major insights. They reveal that the first stage of antigen transfer, antigen export from infected cells, clearly benefits the pathogen, by reducing antigen presentation and CD4 T cell activation by infected cells. They also reveal that the second stage, antigen uptake and presentation by uninfected cells, provides incomplete compensation for the decreased antigen presentation by infected cells, indicating that the net effect of antigen export is to diminish activation of antigen-specific CD4 T cells at the site of infection.
Antigen export is a quantitatively important route for trafficking of mycobacterial antigens produced by intraphagosomal bacteria, as indicated by the 3-fold increase in activation of Ag85B-specific CD4 T cells when antigen export was blocked by depletion of kinesin-2 ( Figure 6A ). This implies that more antigen enters the export pathway than enters the MHC class II pathway in M. tuberculosis-infected cells. Diverting antigen to the export pathway has functional significance for survival of the bacteria, as blockade of antigen export also improves CD4 T-cell-dependent control of intracellular infection. This finding is especially relevant in light of our previous results using mixed (MHC II À/À and MCH II +/+ ) bone marrow chimeric mice that revealed that CD4 T cells must directly recognize infected lung DCs and macrophages to control intracellular infection in vivo (Srivastava and Ernst, 2013) . By exporting bacterial antigens, M. tuberculosis-infected cells reduce the availability of antigen for presentation on MHC class II, diminishing their ability to be recognized by and to activate CD4 effector cells, thereby promoting bacterial persistence. A limitation of the present work is that we have not yet quantitated the impact of antigen export on bacterial persistence in vivo; additional experiments are needed to reveal this important information. In this and our previous report (Srivastava and Ernst, 2014) , we found that all of the M. tuberculosis antigens that we examined are exported from infected cells and share a kinesin-2-dependent export pathway. While this establishes that antigen export is not unique to Ag85B, the antigen we studied in most detail, it raises the question whether all mycobacterial antigens are diverted from the MHC class II pathway and exported to a similar extent. One common property of the antigens we have examined so far is that they are secreted by the bacteria. These proteins may accumulate to especially high concentrations in the intra- phagosomal space and therefore might be particularly prone to export by intracellular vesicles that bud from the phagosome membrane and enter the export pathway. Further studies of the intracellular trafficking of antigens that are not secreted by the bacteria are warranted, as our findings imply that antigens that are not exported from infected cells might induce more productive CD4 T cell activation and thus might be especially useful TB vaccine antigens.
Our finding that antigen export provides a mechanism for evasion of CD4 T cell activation by infected cells may also help explain the observation that few, if any, human T cell epitopes of M. tuberculosis exhibit evidence of escape mutations (Comas et al., 2010; Copin et al., 2014; Coscolla et al., 2015) . The efficiency of antigen export and evidence that it limits activation of CD4 T cells by infected cells implies that it may reduce selection pressure from T cell recognition so that epitope escape mutations are neither selected nor necessary for persistence and proliferation of M. tuberculosis.
The results reported here provide initial insight into key mechanistic elements of antigen export. We found that Ag85B is present in extraphagosomal membrane vesicles, that one or more steps in antigen export depends on the GTPase activity of dynamin-2, and that AEVs are associated with microtubules and the motor protein, kinesin-2. We also determined that disruption of microtubules or depletion of kinesin-2 decreases antigen export. Notably, we found that decreasing antigen export by kinesin-2 depletion improved the ability of M. tuberculosis-infected cells to activate Ag85B-specific CD4 T cells and the ability of CD4 T cells to control infection. These findings provide a strong rationale for efforts to identify additional mechanistic steps of antigen export and their essential mediators, including mechanisms for AEVs budding from phagosomes, AEVs targeting through a nondegradative pathway, and AEVs membrane fusion with the plasma membrane for extracellular delivery of bacterial antigens. Such efforts will also clarify the identity of AEVs and their relationship to previously characterized vesicular compartments involved in intracellular protein transport, and will provide insight into whether AEVs are an existing vesicle population that is co-opted by M. tuberculosis, or whether AEVs are generated in response to infection. Identification of specific steps and mediators in the antigen export pathway may guide pharmacological intervention to block antigen export and enhance the efficacy of CD4 T cell responses in control of TB. As the interactions of mycobacterial phagosomes with intracellular vesicle networks have been thought to be limited, the further characterization of AEVs will also shed light on a fundamental interaction of intracellular M. tuberculosis with host cells.
Another important matter is whether antigen export or a similar process contributes to the pathogenesis of other infections. One related phenomenon is the export of typhoid toxin from epithelial cells infected with the agent of typhoid fever, Salmonella enterica serovar Typhi (S. Typhi) (Spanò and Galá n, 2008) . Like M. tuberculosis, S. Typhi resides in vesicles and exports a heterotrimeric toxin from infected cells to intoxicate neighboring uninfected cells. Typhoid toxin appears as intracellular puncta in infected cells; upon release to the extracellular media, typhoid toxin is neutralized by an antibody, indicating that it is no longer contained in a membrane-bound compartment (Spanò and Galá n, 2008) . Export of typhoid toxin requires assembly of the trimeric complex of CdtB, PltA, and PltB, indicating that structural features of PltA and/or PltB are required to target the complex to export vesicles. Our finding that multiple structurally unrelated M. tuberculosis antigens are exported suggests that the export pathway in M. tuberculosis-infected cells does not require specific structural features for a protein to enter and to be transported. Together, the findings with typhoid toxin and M. tuberculosis antigen export provide evidence for a mechanism beyond cytokine secretion, bacterial membrane vesicle shedding (Rath et al., 2013) , exosome shedding (Bhatnagar et al., 2007) , and apoptotic vesicles (Divangahi et al., 2010; Winau et al., 2006) for pathogen-infected cells to communicate with and affect the function of other cells, by release of soluble pathogen proteins through an intracellular nondegradative pathway. Further characterization of the antigen export pathway of M. tuberculosis-infected cells will provide opportunities and targets to enhance the efficacy of natural and vaccine-induced T cells in TB and may also provide means of intervening in the pathogenesis of other infectious diseases.
EXPERIMENTAL PROCEDURES Mice
Mice were bred and housed in specific pathogen-free facilities. Intratracheal administration of infected bone-marrow-derived DCs was done as we recently described (Srivastava and Ernst, 2014) followed by harvest and processing of MDLN and lungs into single cell suspensions. The staining and quantitation of antigen-specific CD4 T cell proliferation and bacteria in tissues was performed as previously described (Wolf et al., 2008; Wolf et al., 2007) . All procedures were approved by the NYU School of Medicine IACUC.
Bone-Marrow-Derived DCs and Macrophages
CD11c
+ DCs were sorted following culture of fresh or cryopreserved bone marrow in bone-marrow-derived DC (BMDC) medium (RPMI 1640 with 10% heat-inactivated FBS, 2 mM L-glutamine, 1 mM sodium pyruvate, 13 b-ME, 10 mM HEPES) containing 10 ng/ml recombinant murine GM-CSF for 7 days. For siRNA treatments, CD11c + DCs were sorted on day 5. Macrophages were generated by culture of bone marrow cells in bone-marrowderived macrophage (BMDM) medium (DMEM with 10% heat-inactivated FBS, 2 mM L-glutamine, 1 mM sodium pyruvate, 13 b-ME, 10 mM HEPES, and 20 ng/ml recombinant murine M-CSF from Peprotech) for 6 days prior to use in the designated assays.
Immunofluorescence and Confocal microscopy BMDCs on coverslips were stained with biotinylated anti-CD45.2 (Biolegend) followed by streptavidin Alexa-647 (Invitrogen) and fixed overnight in PFA. Fixed cells were permeabilized in cold PBS/0.5% Triton X-100 (5 min on ice), washed, and stained for Ag85, and transferrin receptor, tubulin, KIF3A, dynamin 2, or MHC-II (see Supplemental Experimental Procedures). Finally, coverslips were washed and mounted in Vectashield mounting medium (Vector Labs). An automated TCS SP5 II confocal microscope (Leica) with a 633/1.4 oil immersion lens was used to acquire 3D image stacks (0.3-0.5 mm) using appropriate laser combinations. Representative image stacks of average intensity from relevant channels were merged and converted to RGB format using Image J. All related groups were subjected to similar color settings for each color channel.
Quantitation of Colocalization
Colocalization analysis was performed on raw images in Volocity image analysis software using the built-in Manders' overlap coefficient colocalization feature. Multiple confocal images were subjected to background subtraction followed by colocalization analysis on a per-cell basis. The data was presented as Manders' colocalization coefficient of Ag85 with respect to other proteins; that is, the fraction of Ag85 that colocalized with the other protein of interest in each analyzed cell (Dunn et al., 2011) . The data represent two to three independent experiments and 100-300 cells per experiment.
Cryo-Immunoelectron Microscopy BMDC infected with wild-type M. tuberculosis H37Rv or Ag85B-deficient M. tuberculosis (Wolf et al., 2008) were washed and fixed (PBS/2% PFA/ 0.2% glutaraldehyde) as pellets that were then processed for cryo-immunoelectron microscopy as described in the Supplemental Experimental Procedures.
siRNA ON-Target plus SMART pool Kif3a siRNA (L-042111-01), Kifap3 (KAP3) siRNA (L-047278-01), and ON-Target plus non-targeting control siRNA (D-001810-01) were obtained from GE Dharmacon (details in Table S1 ).
Generation of Conditioned Media and In Vitro Antigen Transfer Assay
BMDMs or CD11c + DCs were treated with control or targeting siRNAs beginning on day 5 of culture. After 48 hr of exposure to siRNAs, the cells were infected overnight with M. tuberculosis (see Supplemental Experimental Procedures for details). After overnight infection, cells were washed, treated with amikacin, washed again, and cultured further in fresh BMDC or BMDM medium that was harvested after 20-24 hr as conditioned medium (CM). The CM was sterile filtered and added to uninfected BMDC in the presence of P25TCR-Tg CD4 + Th1 effector cells for 60 hr, as described previously (Srivastava and . Culture supernatants were collected at 60 hr and used for IFNg quantitation by ELISA (BD Biosciences). 
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We thank the NYU imaging core facility (Feng-Xia [Alice] Liang for cryo-immunoelectron microscopy and Yan Deng for assistance with confocal microscopy) (both supported by NCRR S10 RR024708). We greatly appreciate early guidance by Sergio Grinstein, Ph.D. and are grateful to members of the Ernst Lab for helpful discussions and suggestions on early drafts of the manuscript. were sorted by FACS from GFP-positive (i.e, infected) and GFP-negative (i.e., uninfected) lung cells obtained from mice infected with GFP-expressing M. tuberculosis H37Rv 27 days earlier and subsequently used to stimulate P25TCR-Tg Th1 CD4 cells without addition of exogenous antigen. Four days later supernatants were collected and used to quantitate IFNγ by ELISA. The GFP-negative (i.e., uninfected) cell subsets contained fewer than 1 bacterial colony-forming unit (CFU) per 1000 sorted cells. The bar marked "none" indicates IFNγ secretion by P25TCR-Tg Th1 cells incubated in parallel in the absence of any antigen-presenting cells. In the same experiment, separate wells of the sorted uninfected cells received added peptide 25 at the same time as P25TCR-Tg Th1 cells, which stimulated release of increased amounts of IFNγ (mDC: 18,935 ± 740; RM: 8002 ± 2453; Monos: 6334 ± 2813 ; all as pg/ml, mean ± SD). Right panel: As a control, lung myeloid cell subsets were sorted from uninfected mice that received LPS intratracheally 3 days before harvest and sorting. After cells from each sorted subset were incubated with P25TCR-Tg Th1 cells, IFNγ secretion was quantitated by ELISA. In the same experiment, separate wells of the sorted uninfected cells received added peptide 25 at the same time as P25TCR-Tg Th1 cells, which stimulated release of increased amounts of IFNγ (mDC: 11,954 ± 1402; RM: 3.547 ± 72; Monos: 1,126 ± 90; all OCT at day 24 post infection, sectioned, fixed and stained with anti-CD11c (blue) and anti-Ag85B (red). White arrows in the left panel point to bacteria-free CD11c + DCs that contain Ag85. Scale bars 20 µm. Data represent 2-3 independent experiments *p < 0.05; **p < 0.01; ***p < 0.001 (Student's t-test) . Residual staining of Ag85 seen in the section from the mouse infected with H37Rv:ΔAg85B is attributable to recognition of Ag85A and Ag85C, which are recognized by the antibody and which are exported from infected cells (Figures 1A and 3C, and Srivastava and Ernst, 2014) . IFNγ secretion by P25TCR-Tg CD4 + effector T cells when co-cultured with uninfected DC that received conditioned medium (CM) generated from infected, siRNA treated, DC as shown in panel A. Control wells did not receive any CM. Culture supernatants were collected at 60 h and assayed for IFNγ by ELISA. Data are expressed as mean ± SEM *p < 0.05; **p < 0.01; ***p < 0.001 (Student's t-test). (C) Band intensities for Ag85B, CFP-10, ESAT-6 and EsxH proteins from the western blot in Figure 3D were calculated using Image J to show the relative decrease in their export to conditioned medium generated from DC treated with siRNA targeting kinesin-2 and infected with M. tuberculosis (Fig 3D, lane 2) . The band intensity for each of the proteins present in CM from control siRNA treated DC (Fig 3D, lane1) show expression of activated caspase 3 in control or kinesin-2 depleted CD11c+ DC following overnight infection with M. tuberculosis (MOI 1), indicating that kinesin-2 depletion does not accelerate or retard apoptosis of DC. (E) IL1-β (left panel) and TNF (right panel) release by control or kinesin-2 depleted CD11c+ DC following 24 hours of infection with M. tuberculosis (MOI 1). (F) Quantitation of live bacteria per 1000 infected DC (MOI 1) treated with varying amounts of either a non-targeting siRNA or kinesin-2 siRNA and cultured in the absence of P25TCR-Tg CD4 effector T cells. (G) Quantitation of live bacteria per 1000 wild-type and MHC-II -/-DC that were infected (MOI 1) with either H37Rv or Ag85B-deficient H37Rv (H37RvΔ85B) and cultured for 20 h in the absence of P25TCR-Tg CD4 effector T cells. Data are expressed as mean ± SEM *p < 0.05; **p < 0.01; ***p < 0.001, NS not significant (Student's t-test) Table S1 related to Figures 3, 4 , 5, and 6: Names and target sequences of siRNAs used in these studies. Target 
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